Home Cart Sign in  
Chemical Structure| 32188-75-3 Chemical Structure| 32188-75-3

Structure of 32188-75-3

Chemical Structure| 32188-75-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 32188-75-3 ]

CAS No. :32188-75-3
Formula : C12H13N3O2
M.W : 231.25
SMILES Code : N#CC1=CC([N+]([O-])=O)=CC=C1N2CCCCC2
MDL No. :MFCD05365582
InChI Key :AFQKJSKHZCXGLQ-UHFFFAOYSA-N
Pubchem ID :4811199

Safety of [ 32188-75-3 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Computational Chemistry of [ 32188-75-3 ] Show Less

Physicochemical Properties

Num. heavy atoms 17
Num. arom. heavy atoms 6
Fraction Csp3 0.42
Num. rotatable bonds 2
Num. H-bond acceptors 3.0
Num. H-bond donors 0.0
Molar Refractivity 69.43
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

72.85 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.84
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.44
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.08
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.83
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.31
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.5

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.94
Solubility 0.265 mg/ml ; 0.00115 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.61
Solubility 0.0564 mg/ml ; 0.000244 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.6
Solubility 0.586 mg/ml ; 0.00254 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.98 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

1.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.11

Application In Synthesis of [ 32188-75-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 32188-75-3 ]

[ 32188-75-3 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 32188-75-3 ]
  • [ 34595-33-0 ]
YieldReaction ConditionsOperation in experiment
92% for 0.5 h; The compound 5-nitro-2- (piperidin-1-yl) benzoic acid was subjected to reduction reaction by NaBH4 for 30 min, followed by 2.0 g of a yellow solid (Compound 11)
87% With hydrogen In methanol for 16 h; Step 2; 2-(1-piperidinyl)-5-(amino)benzonitrile; The 2-(1-piperidinyl)-5-(nitro)benzonitrile (25 g, 108 mmol) was solubilized in methanol (400 ml). A spatula tip of Pd/C was added to the mixture and the crude was stirred for 16 hours under hydrogen atmosphere. The mixture was filtered on Celite.(R)., concentrated and the expected product was isolated by recrystallization in an equimolar volume of dichloromethane and cyclohexane. Yield: 87percent
References: [1] Patent: CN106892871, 2017, A, . Location in patent: Paragraph 0135; 0138; 0139.
[2] Patent: US2006/79696, 2006, A1, . Location in patent: Page/Page column 38.
[3] Patent: EP1176140, 2002, A1, . Location in patent: Page 54.
  • 2
  • [ 32188-75-3 ]
  • [ 7439-89-6 ]
  • [ 34595-33-0 ]
References: [1] Patent: US2003/203909, 2003, A1, .
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 32188-75-3 ]

Aryls

Chemical Structure| 451459-92-0

A838692 [451459-92-0]

2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile

Similarity: 0.91

Chemical Structure| 51762-67-5

A197272 [51762-67-5]

3-Nitrophthalonitrile

Similarity: 0.78

Chemical Structure| 612-24-8

A757779 [612-24-8]

2-Nitrobenzonitrile

Similarity: 0.78

Chemical Structure| 26830-95-5

A596581 [26830-95-5]

4-Methyl-2-nitrobenzonitrile

Similarity: 0.77

Chemical Structure| 6574-15-8

A193800 [6574-15-8]

1-(4-Nitrophenyl)piperidine

Similarity: 0.76

Nitroes

Chemical Structure| 451459-92-0

A838692 [451459-92-0]

2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile

Similarity: 0.91

Chemical Structure| 30450-62-5

A482051 [30450-62-5]

7-Nitro-1,2,3,4-tetrahydroquinoline

Similarity: 0.78

Chemical Structure| 51762-67-5

A197272 [51762-67-5]

3-Nitrophthalonitrile

Similarity: 0.78

Chemical Structure| 612-24-8

A757779 [612-24-8]

2-Nitrobenzonitrile

Similarity: 0.78

Chemical Structure| 26830-95-5

A596581 [26830-95-5]

4-Methyl-2-nitrobenzonitrile

Similarity: 0.77

Nitriles

Chemical Structure| 451459-92-0

A838692 [451459-92-0]

2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile

Similarity: 0.91

Chemical Structure| 51762-67-5

A197272 [51762-67-5]

3-Nitrophthalonitrile

Similarity: 0.78

Chemical Structure| 612-24-8

A757779 [612-24-8]

2-Nitrobenzonitrile

Similarity: 0.78

Chemical Structure| 26830-95-5

A596581 [26830-95-5]

4-Methyl-2-nitrobenzonitrile

Similarity: 0.77

Chemical Structure| 63365-23-1

A162741 [63365-23-1]

2-Amino-6-nitrobenzonitrile

Similarity: 0.75

Related Parent Nucleus of
[ 32188-75-3 ]

Piperidines

Chemical Structure| 6574-15-8

A193800 [6574-15-8]

1-(4-Nitrophenyl)piperidine

Similarity: 0.76

Chemical Structure| 5367-58-8

A116055 [5367-58-8]

5-Nitro-2-(piperidin-1-yl)aniline

Similarity: 0.71

Chemical Structure| 188604-99-1

A134303 [188604-99-1]

2-(4-Methylpiperidin-1-yl)-5-nitroaniline

Similarity: 0.70

Chemical Structure| 34595-33-0

A236948 [34595-33-0]

5-Amino-2-(piperidin-1-yl)benzonitrile

Similarity: 0.69

Chemical Structure| 166438-83-1

A412324 [166438-83-1]

(1-(4-Nitrophenyl)piperidin-3-yl)methanol

Similarity: 0.68